Anti-IL-17F antibodies
US8137671B2 · kind B2 · utility
4Cited by
30References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2010 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | May 5, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides fully human monoclonal antibodies that recognize IL-17F and/or the heterodimeric IL-17A/IL-17F complex, but do not recognize IL-17A. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.